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Background: Adult-onset Still’s disease is a rare inflammatory condition of unknown origin characterized by high
spiking fever, arthralgia, arthritis, myalgia, salmon-colored evanescent rash, and hepatosplenomegaly. The diagnosis of
adult-onset Still’s disease requires the exclusion of other possible disorders because it lacks specific clinical and
histopathological findings. Adult-onset Still’s disease rarely become fatal due to visceral involvements such as
disseminated intravascular coagulation.
Case presentation: A 22-year-old Chinese female presented to our medical center with high spiking fever for
one week, myalgia for two weeks, and arthralgia and pink maculopapular rash for four weeks. She developed
disseminated intravascular coagulation on the fourth day after admission. There was no other explanation for
the fever and rash, including infection, malignancy, and collagenosis. Together, the high spiking fever, salmon-colored
rash, splenomegaly, and excess hepatic enzyme, indicated adult-onset Still’s disease based on the Yamaguchi criteria.
Therefore, prednisolone therapy was initiated. The combination of nafamostat mesilate and prednisolone therapies
caused a rapid reduction in the fever and rash. The inflammatory markers decreased immediately, and disseminated
intravascular coagulation improved. Her symptoms resolved with low-dose prednisolone treatment, and she was
monitored thereafter at our outpatient clinic.
Conclusion: The previous use of nonsteroidal anti-inflammatory drugs could have caused disseminated intravascular
coagulation in this patient with adult-onset Still’s disease. We propose that physicians should consider the possibility of
disseminated intravascular coagulation as a complication during the course of adult-onset Still’s disease and suggest
that prednisolone therapy should be initiated in the early stages of adult-onset Still’s disease.
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Adult-onset Still’s disease (AOSD) is a systemic inflam-
matory disorder of unknown etiology characterized by
high spiking fever, arthralgia, arthritis, myalgia, salmon-
colored evanescent rash, and hepatosplenomegaly [1,2].
The diagnosis of AOSD requires the exclusion of other
possible disorders because it lacks specific clinical and
histopathological findings [3,4]. During the course of
AOSD, life-threatening conditions such as hepatic in-
volvement, cardiac tamponade, respiratory distress syn-
drome, or pancytopenia caused by hemophagocytic* Correspondence: masanori19810813@yahoo.co.jp
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unless otherwise stated.syndrome (HS) occasionally develop [5]. However, cases
of AOSD with disseminated intravascular coagulation
(DIC) are not common [6-10]. We report a case of
AOSD with DIC, which was dramatically improved by
prednisolone.
Case presentation
A 22-year-old Chinese female presented to our medical
center with a high spiking fever and a pink maculopap-
ular rash on the trunk, face, and limb for one week
(Figure 1), myalgia for two weeks, and arthralgia for
four weeks. Her fever was between 35°C and 39°C; its
occurrence correlates with the appearance of the rash,
and it was not relieved by treatment. She had been tak-
ing NSAID called loxoprofen for her fever for a fewl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Picture of the patient showing salmon-colored rash
on her face and trunk.
Figure 2 Computed tomography images showing splenomegaly.
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lergies, a past medical history, alcoholism, herbal treat-
ment, insect bites, or contact with any animal. She did not
travel to any foreign country for the past two years.
Physical examination revealed high fever, a regular
pulse of 100 beats per min, and normal blood pressure
(116/84 mmHg). There were no signs of anemia, jaun-
dice, lymph node swelling, hepatosplenomegaly or goi-
ter. Auscultation of the lungs revealed no rale, and her
heart function sounded normal. Myalgia was detected in
the arms and legs by pressure algometry.
Blood sample analysis revealed high levels of C-reactive
protein (3.03 mg/dL; normal: 0–0.3 mg/dL), lactate de-
hydrogenase (751 IU/L; normal: 109–244 IU/L), aspartate
transaminase (76 IU/L; normal: 10–40 IU/L), ferritin
(1027 ng/ml; normal: 10–291 ng/ml), and creatinine phos-
phokinase (239 IU/L; normal: 40–149 IU/L). In contrast,
the patient had normal white blood cell counts (6.4 × 103/
μL; normal: 3.1-8.0 × 103/μL), hemoglobin (12.2 g/dL; nor-
mal: 10.1-14.5 g/dL), and platelet count (10.5 × 104/μL;
normal: 11.0-34.0 × 104/μL), γ-glutamyltransferase (18 IU/
L; normal: 8–68 IU/L), alanine transaminase (24 IU/L;
normal: 5–44 IU/L) and alkaline phosphatase (173 IU/L;
normal: 80–260 IU/L).
Serology tests were negative for the rheumatoid factor,
anti-nuclear antibodies, anti-DNA antibodies, anti-neu-
trophil cytoplasmic antibodies, and anti-Jo-1 antibodies.
There was no marker of recent infection, including
hepatitis B antigen, hepatitis C virus, HIV antibodies,
Mycobacterium tuberculosis antigen, Epstein–Barr virus,
cytomegalovirus, herpes simplex viruses, mycoplasma
pneumonia, Human parvovirus B19, Rickettsia japonica,
or Orientia tsutsugamushi.Computed tomography (CT) images revealed spleno-
megaly, in the absence of abscess or tumor (Figure 2).
Echocardiography was negative for endocarditis.
After admission, the high fever persisted, with increas-
ing levels of hepatic and biliary enzymes (Figure 3). On
day 4 after admission, the platelet count suddenly de-
creased to 6.3 × 104/μL, and the fibrinogen level de-
creased to 122 mg/dL (normal: 190–430 mg/dL). In
contrast, the patient had excess fibrin degradation prod-
uct (FDP; 45.5 μg/mL; normal: 1–10 μg/mL), and a high
prothrombin time-international normalized ratio (PT-
INR: 1.23; control: 1.0). Based on these data, she was di-
agnosed with DIC and nafamostat mesilate (200 mg/day)
therapy was initiated immediately.
A bone marrow biopsy showed hemophagocytosis, no
blast cells, and no malformation (Figure 4). Because the
patient had fever, splenomegaly, and hypofibrinogen-
emia, but no evidence of malignancy, we diagnosed HS
on the basis of these findings [11].
There was no other explanation for the fever and rash,
including infection, malignancy, and collagenosis. To-
gether, the high spiking fever, salmon-colored rash,
splenomegaly, and excess hepatic enzyme, indicated
AOSD based on the Yamaguchi criteria [9]. Therefore,
prednisolone (30 mg/day) therapy was initiated.
The combination of nafamostat mesilate and prednisol-
one therapies caused immediate improvement of both the
fever and rash. The inflammatory markers decreased im-
mediately, and DIC improved. On day 34, the dosage of
oral prednisolone was decreased from 30 mg/day to
25 mg/day, and the patient was discharged. Her symptoms
Figure 3 Clinical course of a patient with adult-onset Still’s disease. ALT, alanine transaminase; AST, aspartate transaminase; BT, body temperature;
CRP, C-reactive protein; WBC, white blood cell count.
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she was monitored thereafter at our outpatient clinic.
Conclusions
The present case highlights the difficulty of diagnosing
AOSD. Moreover, our case showed that AOSD could be
a cause of DIC. The diagnosis of AOSD is clinically im-
portant and difficult because the disorder has no specific
laboratory marker. The Yamaguchi criteria are widely
recognized as the most sensitive tool to diagnose AOSD
[12]. Nonetheless, differential diagnosis is necessary to
exclude other diseases, such as an infection (i.e.,Figure 4 Bone marrow showing hemophagocytosis
(black arrow).endocarditis), neoplastic diseases (i.e., lymphomas), or
autoimmune diseases (i.e., vasculitis and polymyositis)
[13,14]. In this case, infection, neoplastic disease, or auto-
immune disease was not revealed by an extensive examin-
ation that included blood test, CT scan, and bone marrow
biopsy.
In general, the treatment of AOSD involves corticoste-
roids, generally medium-high to high doses (0.5–1 mg/
kg/day) of prednisone equivalent [14]. For AOSD pa-
tients with severe visceral involvement, intravenous infu-
sion of high-dose methylprednisolone generally provides
efficient symptom relief. The corticosteroid response
should be detected within a few hours or days [14]. In
our case, prednisolone therapy dramatically reduced the
fever and rash within 3 days.
In patients with AOSD, macrophage hyperactivation
and cytokine overproduction cause liver damage [14,15].
The onset of DIC is precipitated by a decrease in pro-
coagulant factor caused by liver dysfunction [16]. In
some reports, the development of DIC in patients with
AOSD was attributed to the use of nonsteroidal anti-
inflammatory drugs (NSAIDs) [17,18]. It is surmised that
the disease-induced hepatic damage, further aggravated
by aspirin, may be a significant factor in the initiation
and perpetuation of intravascular coagulation [17]. Ac-
cordingly, it is critical to monitor liver enzymes during
the initial stage of AOSD therapy because NSAIDs may
induce severe hepatitis [3]. Another study suggests that
high serum levels of unbound anti-inflammatory drugs,
due to reduced serum albumin binding, may cause
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synthesis [18]. Because our patient was taking loxopro-
fen before her admission to our hospital, this NSAID
may have triggered DIC.
Bone marrow analysis revealed that our patient devel-
oped from HS. This condition is caused by hyperacti-
vated T cells (Th1 cells) and macrophages, and the
subsequent overproduction of cytokines such as IL-1,
IL-6, and IFN-γ [19]. These cytokines contribute to the
development of thrombotic reactions by activation of
vascular endothelial cells and monocytes [20]. Earlier
cases of AOSD complicated with DIC and HS were
treated successfully with NSAIDs, steroids, nafamostat
mesilate, gabexate mesilate, or cyclosporine [6,7,21]. To
avoid the use of NSAIDS, our patient was treated with
nafamostat mesilate and steroid therapy. She responded
well to the treatment and was discharged on low-dose
prednisolone.
In conclusion, we report a case of AOSD complicated
by HS and then DIC. The onset of DIC could be due to
the use of NSAIDs. The differential diagnosis of AOSD
requires several tests to rule out infections, neoplastic
diseases, and autoimmune diseases. However, patients
with AOSD may rapidly develop life-threatening condi-
tions such as DIC. Therefore, we propose that physicians
should be alert to the possibility of DIC as a complica-
tion during the course of AOSD and that prednisolone
treatment should be initiated in the early stages of
AOSD.
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